I‐Fen Chang

470 total citations
16 papers, 285 citations indexed

About

I‐Fen Chang is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, I‐Fen Chang has authored 16 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Hepatology and 3 papers in Surgery. Recurrent topics in I‐Fen Chang's work include Cancer Immunotherapy and Biomarkers (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Melanoma and MAPK Pathways (3 papers). I‐Fen Chang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Melanoma and MAPK Pathways (3 papers). I‐Fen Chang collaborates with scholars based in United States, Australia and Italy. I‐Fen Chang's co-authors include Saul J. Karpen, Beth A. Carter, John A. Goss, Stuart L. Goldstein, Daniel I. Feig, David J. Askenazi, Ewa Elenberg, Neal R. Barshes, Rubén E. Quirós‐Tejeira and John A. Goss and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Annals of Oncology.

In The Last Decade

I‐Fen Chang

16 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Fen Chang United States 8 138 60 54 43 42 16 285
Maham Hayat United States 11 92 0.7× 45 0.8× 48 0.9× 8 0.2× 32 0.8× 56 292
Hui‐Ling Yeoh Australia 7 182 1.3× 98 1.6× 28 0.5× 38 0.9× 36 0.9× 17 323
Ali Süner Türkiye 9 87 0.6× 34 0.6× 75 1.4× 23 0.5× 23 0.5× 28 248
Simone Kathemann Germany 10 35 0.3× 54 0.9× 154 2.9× 12 0.3× 62 1.5× 30 306
Howard M. Dubner United States 5 180 1.3× 82 1.4× 229 4.2× 28 0.7× 28 0.7× 10 282
M Renoux France 8 40 0.3× 33 0.6× 13 0.2× 21 0.5× 26 0.6× 23 286
Daniel Wenning Germany 8 82 0.6× 59 1.0× 147 2.7× 6 0.1× 145 3.5× 13 298
Virginia Leiro Spain 10 67 0.5× 141 2.4× 51 0.9× 18 0.4× 70 1.7× 18 377
C. Ball United Kingdom 9 38 0.3× 66 1.1× 152 2.8× 11 0.3× 47 1.1× 22 255
Gyan Ranjan India 8 64 0.5× 120 2.0× 139 2.6× 63 1.5× 83 2.0× 22 297

Countries citing papers authored by I‐Fen Chang

Since Specialization
Citations

This map shows the geographic impact of I‐Fen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Fen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Fen Chang more than expected).

Fields of papers citing papers by I‐Fen Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Fen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Fen Chang. The network helps show where I‐Fen Chang may publish in the future.

Co-authorship network of co-authors of I‐Fen Chang

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Fen Chang. A scholar is included among the top collaborators of I‐Fen Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Fen Chang. I‐Fen Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Gerber, David E., James J. Urbanic, Corey J. Langer, et al.. (2017). Randomized phase III trial of concurrent chemoradiation followed by nivolumab or placebo for locally advanced non-small cell lung cancer (NSCLC) (RTOG 3505).. Journal of Clinical Oncology. 35(15_suppl). TPS8579–TPS8579. 7 indexed citations
3.
Hauschild, Axel, Paul B. Chapman, Caroline Robert, et al.. (2016). Impact of key prognostic factors on long-term overall survival in BRAFV600-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study. Melanoma Research. 2 indexed citations
4.
5.
6.
7.
Margolin, Kim, Ahmad A. Tarhini, Sumati Rao, et al.. (2015). Effectiveness and safety of ipilimumab therapy in advanced melanoma: evidence from clinical practice sites in the US. The Journal of Community and Supportive Oncology. 13(4). 131–138. 5 indexed citations
8.
9.
Elidemir, Okan, I‐Fen Chang, M.G. Schecter, & George B. Mallory. (2007). BK virus‐associated hemorrhagic cystitis in a pediatric lung transplant recipient. Pediatric Transplantation. 11(7). 807–810. 16 indexed citations
10.
Barshes, Neal R., I‐Fen Chang, Saul J. Karpen, Beth A. Carter, & John A. Goss. (2006). Impact of Pretransplant Growth Retardation in Pediatric Liver Transplantation. Journal of Pediatric Gastroenterology and Nutrition. 43(1). 89–94. 45 indexed citations
11.
Quirós‐Tejeira, Rubén E., et al.. (2005). Treatment of acute tacrolimus whole‐blood elevation with phenobarbital in the pediatric liver transplant recipient. Pediatric Transplantation. 9(6). 792–796. 15 indexed citations
12.
Quirós‐Tejeira, Rubén E., I‐Fen Chang, Jaymee D. Scott, John A. Goss, & Jun Teruya. (2005). Mycophenolate Mofetil in the Management of Alloimmune Hemolytic Anemia in ABO‐Compatible but Non‐Identical Pediatric Liver Transplantation. Journal of Pediatric Gastroenterology and Nutrition. 41(1). 125–128. 1 indexed citations
13.
Chang, I‐Fen, et al.. (2004). P0096 PP POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS TREATED WITH ANTI‐CD20 MONOCLONAL ANTIBODY: A LONG‐TERM OUTCOME STUDY. Journal of Pediatric Gastroenterology and Nutrition. 39(S1). 1 indexed citations
14.
Quirós‐Tejeira, Rubén E., et al.. (2004). P0096 PP POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS TREATED WITH ANTI-CD20 MONOCLONAL ANTIBODY: A LONG-TERM OUTCOME STUDY. Journal of Pediatric Gastroenterology and Nutrition. 39(Supplement 1). S93–S93. 2 indexed citations
15.
Askenazi, David J., Stuart L. Goldstein, I‐Fen Chang, Ewa Elenberg, & Daniel I. Feig. (2004). Management of a Severe Carbamazepine Overdose Using Albumin-Enhanced Continuous Venovenous Hemodialysis. PEDIATRICS. 113(2). 406–409. 48 indexed citations
16.
Carter, Beth A., Saul J. Karpen, Rubén E. Quirós‐Tejeira, et al.. (2002). Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation. 74(7). 1050–1052. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maham Hayat Breakdown of academic impact, for papers by Hui‐Ling Yeoh Breakdown of academic impact, for papers by Ali Süner Breakdown of academic impact, for papers by Simone Kathemann Breakdown of academic impact, for papers by Howard M. Dubner Breakdown of academic impact, for papers by M Renoux Breakdown of academic impact, for papers by Daniel Wenning Breakdown of academic impact, for papers by Virginia Leiro Breakdown of academic impact, for papers by C. Ball Breakdown of academic impact, for papers by Gyan Ranjan
Rankless by CCL
2026